Citations

PromoCell uses the Bioz AI engine to display product citations. This content is currently blocked due to your cookie preferences.

3D Tumorsphere Medium XF
Add to Wishlist

Serum-free and xeno-free medium for the cultivation of cancer cell lines as 3D tumorspheres.

Unit 250000 ml
Cat.No.
Only %1 left
€214.00
Formulation

Choose Type

Currently In stock

Key benefits:

  • Establish 3D tumorsphere cultures directly from 2D cancer cell lines
  • Suitable for long-term routine culture of tumorspheres
  • Compatible with most commonly used cancer cell lines
  • Xeno-free and serum-free formulation

Components:

  • 3D Tumorsphere Basal Medium
  • 3D Tumorsphere SupplementMix

3D cancer spheroids and organoids are popular in vitro models that often better reflect the in vivo tumor environment than some 2D models. Within tumors and tumor spheroids, cancer stem cells (CSCs) are a small subpopulation of cells that play a key role in tumor initiation, recurrence, metastasis, and even resistance to cancer therapies. CSCs exhibit stem cell-like characteristics including self-renewal capabilities and tumorigenicity.

As a part of our Cancer Media Toolbox, our 3D Tumorsphere Medium XF is ideal for isolation and 3D long-term cultivation of CSCs. The 3D Tumorsphere Medium XF supports enrichment and maintenance of CSCs as well as further differentiated cancer cells with high cell proliferation rates.

The medium helps you create a reducible in vivo-like system by promoting the formation of homogenous tumorspheres through serial passaging of the 3D culture.

When it comes to the characterization of cultured CSCs, the tumorsphere formation efficiency (TFE) assay represents the gold standard. The TFE assay describes the percentage of cells within a cancer cell culture that can form a sphere from a single cell. Since only stem-like cells can form spheroids from a single cell, TFE values are a quantitative measurement that correlates with cancer metastasis and aggressiveness. In experiment where MCF-7 cells have been cultured in 3D Tumorsphere Medium XF, the TFE value significantly improved from 2% to 28% over 9 passages.

 

List of cell types tested for serial passage with our 3D Tumorsphere Medium XF:

Tissue Tested cell lines Cell lines origin
Brain U-87 MG grade IV glioblastoma / astrocytoma of the human brain
Breast MCF-7 pleural effusion of metastatic human breast adenocarcinoma
Breast MDA-MB-231 pleural effusion of metastatic human breast adenocarcinoma (triple-negative)
Colon HT-29 human colon adenocarcinoma
Colon CT26 mouse colon cancer cell line
Connective tissue HT1080 human fibrosarcoma
Liver HepG2 hepatocellular carcinoma of the human liver
Lung A-549 human lung carcinoma
Pancreas Panc-1 epithelioid carcinoma of the human pancreatic duct
Prostate LNCaP lymph node metastasis of human prostate adenocarcinoma
Skin A-431 epidermoid carcinoma of the human skin

 

.

Image
Figure 1.HT1080 fibrosarcoma cells after 10 serial passages.
Image
Figure 2.Proliferation curves of various established cancer cell lines expanded by serial passage of 3D tumorsphere cultures.
Image
Figure 3.Serial passage of MCF-7 cells in the 3D Tumorsphere Medium XF results in a significant increase of TFE from 2% in P1 to 28% in P9.

PromoCell uses the Bioz AI engine to display product citations. This content is currently blocked due to your cookie preferences.

Accept cookies and load content

Recommended products

Freezing Medium Cryo-SFM

Freezing Medium Cryo-SFM

Defined, animal-component free, and protein-free cryopreservation medium.
€65.00
Primary Cancer Culture System

Primary Cancer Culture System

A complete defined and animal-component free cell culture solution designed for the selective culture of malignant cells derived from primary tumors or patient-derived xenografts.
€809.00
Cancer Cell Line Medium XF

Cancer Cell Line Medium XF

Serum-free and xeno-free medium for the standardized in vitro cultivation of established cancer cell lines. Fibronectin or vitronectin coating required.
€216.00
Copyright © 2013-present Magento, Inc. All rights reserved.